Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (251-260 of 760) with videos related to

Pageof 76
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 31, 2022
Antiplatelet therapy after percutaneous coronary interventionDominick J Angiolillo, Mattia Galli, Jean-Philippe Collet, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCIRosanne F Vogel, Ronak Delewi, Lina Badimon, et al.
Journal of Thrombosis and Thrombolysis|September 1, 2022
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery diseaseMattia Galli, Fabiana Rollini, Latonya Been, et al.
Revista Espanola De Cardiologia (English Ed.)|July 26, 2011
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitusJosé L Ferreiro, Masafumi Ueno, Bhaloo Desai, et al.
Journal of the American Heart Association|July 2, 2021
Cangrelor: Clinical Data, Contemporary Use, and Future PerspectivesLeonardo De Luca, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Vascular Health and Risk Management|May 14, 2009
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationClarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, et al.
Journal of the American College of Cardiology|October 19, 2013
Platelet function and genetic testingDominick J Angiolillo, José Luis Ferreiro, Matthew J Price, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 28, 2016
Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case seriesIgnacio M Seropian, Dominick J Angiolillo, Martin M Zenni, et al.
Journal of the American College of Cardiology|September 12, 2009
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marín, Rocío González-Conejero, Piera Capranzano, et al.
Clinical Pharmacokinetics|March 17, 2023
Clinical Pharmacokinetics and Pharmacodynamics of CSL112Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, et al.
Pageof 76

Showing results (251-260 of 760) with videos related to

Sort By:
Pageof 76
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 31, 2022
Antiplatelet therapy after percutaneous coronary interventionDominick J Angiolillo, Mattia Galli, Jean-Philippe Collet, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCIRosanne F Vogel, Ronak Delewi, Lina Badimon, et al.
Journal of Thrombosis and Thrombolysis|September 1, 2022
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery diseaseMattia Galli, Fabiana Rollini, Latonya Been, et al.
Revista Espanola De Cardiologia (English Ed.)|July 26, 2011
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitusJosé L Ferreiro, Masafumi Ueno, Bhaloo Desai, et al.
Journal of the American Heart Association|July 2, 2021
Cangrelor: Clinical Data, Contemporary Use, and Future PerspectivesLeonardo De Luca, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Vascular Health and Risk Management|May 14, 2009
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationClarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, et al.
Journal of the American College of Cardiology|October 19, 2013
Platelet function and genetic testingDominick J Angiolillo, José Luis Ferreiro, Matthew J Price, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 28, 2016
Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case seriesIgnacio M Seropian, Dominick J Angiolillo, Martin M Zenni, et al.
Journal of the American College of Cardiology|September 12, 2009
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marín, Rocío González-Conejero, Piera Capranzano, et al.
Clinical Pharmacokinetics|March 17, 2023
Clinical Pharmacokinetics and Pharmacodynamics of CSL112Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, et al.
Pageof 76